COVID‐19 vaccine causing Guillain‐Barre syndrome, a rare potential side effect
Ahmad Matarneh, Alia Hani Mohammed Albattah, Khalid Farooqui, Mohamed Ghamoodi, Mohammed Alhatou
Abstract
Patients with neurological symptoms should be enquired about recent vaccination history. It is important after the COVID-19 mRNA vaccine, which is newly introduced as it might link to the development of a wider variety of neurological diseases.
Topics & Concepts
MedicineGuillain-Barre syndromeCoronavirus disease 2019 (COVID-19)VaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPediatricsVirologyIntensive care medicineImmunologyOutbreakInternal medicineDiseaseInfectious disease (medical specialty)Peripheral Neuropathies and DisordersLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research